Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$832M |
| 2 |
Johnson & Johnson
JNJ
|
+$706M |
| 3 |
Datadog
DDOG
|
+$549M |
| 4 |
Amazon
AMZN
|
+$442M |
| 5 |
Eli Lilly
LLY
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Workday
WDAY
|
+$1.22B |
| 2 |
AbbVie
ABBV
|
+$1.07B |
| 3 |
Advanced Micro Devices
AMD
|
+$817M |
| 4 |
Amgen
AMGN
|
+$706M |
| 5 |
Honeywell
HON
|
+$659M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.69% |
| 2 | Healthcare | 17.58% |
| 3 | Consumer Discretionary | 10.69% |
| 4 | Financials | 10.23% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Zurn Elkay Water Solutions
ZWS
$8.61B
| $149M | 0.08% |
4,006,596
+245,258
| +7% | +$9.35M |
|
227
Teva Pharmaceuticals
TEVA
$39.2B
| $148M | 0.08% |
6,737,625
+1,945,688
| +41% | +$35.4M |
|
|
AVDL
228
DELISTED
Avadel Pharmaceuticals
AVDL
| $148M | 0.08% |
14,080,219
+753,332
| +6% | +$9.15M |
|
|
CCC
229
CCC Intelligent Solutions
CCC
$3.59B
| $147M | 0.07% |
12,553,813
+4,583
| +0% | +$53.1K |
|
|
SARO
230
StandardAero Inc
SARO
$9.55B
| $146M | 0.07% |
+5,890,511
| New | +$171M |
|
231
Realty Income
O
$61.3B
| $146M | 0.07% |
2,725,360
-34,822
| -1% | -$2.03M |
|
232
Mirion Technologies
MIR
$3.6B
| $145M | 0.07% |
8,330,495
+229,718
| +3% | +$3.56M |
|
233
Crinetics Pharmaceuticals
CRNX
$8.88B
| $143M | 0.07% |
2,795,441
+365,991
| +15% | +$20.5M |
|
234
Euronet Worldwide
EEFT
$3.16B
| $143M | 0.07% |
1,386,382
+20,805
| +2% | +$2.12M |
|
235
Penumbra
PEN
$12.6B
| $142M | 0.07% |
597,077
-71,796
| -11% | -$16.3M |
|
236
United Parcel Service
UPS
$89.3B
| $142M | 0.07% |
1,122,886
+853,388
| +317% | +$112M |
|
237
Dollar Tree
DLTR
$24.7B
| $139M | 0.07% |
1,853,432
+8,670
| +0.5% | +$595K |
|
238
WEC Energy
WEC
$36.5B
| $138M | 0.07% |
1,471,096
+1,433,522
| +3,815% | +$139M |
|
239
Vanguard Total International Stock ETF
VXUS
$151B
| $137M | 0.07% |
2,330,013
-49,338
| -2% | -$3.06M |
|
240
Gates Industrial Corporation Ltd.
GTES
$6.31B
| $135M | 0.07% |
6,569,959
+85,253
| +1% | +$1.72M |
|
241
RTX Corp
RTX
$291B
| $135M | 0.07% |
1,166,464
+189,937
| +19% | +$22.9M |
|
242
BridgeBio Pharma
BBIO
$16.5B
| $135M | 0.07% |
4,907,533
+89,521
| +2% | +$2.31M |
|
243
Bristol-Myers Squibb
BMY
$130B
| $134M | 0.07% |
2,375,593
-1,179,165
| -33% | -$65.9M |
|
244
Elevance Health
ELV
$82.4B
| $134M | 0.07% |
363,526
-22,878
| -6% | -$9.57M |
|
245
AstraZeneca
AZN
$270B
| $134M | 0.07% |
1,022,130
+187,353
| +22% | +$26.2M |
|
246
Edgewise Therapeutics
EWTX
$4.23B
| $133M | 0.07% |
4,983,940
+425,421
| +9% | +$13.5M |
|
247
ITT
ITT
$17B
| $133M | 0.07% |
928,116
+11,980
| +1% | +$1.79M |
|
248
Marriott International
MAR
$99.8B
| $131M | 0.07% |
469,239
-143,813
| -23% | -$39.5M |
|
|
ETNB
249
DELISTED
89bio
ETNB
| $129M | 0.07% |
16,514,056
+1,355,838
| +9% | +$11.2M |
|
250
Public Storage
PSA
$62.2B
| $129M | 0.07% |
431,129
+29,972
| +7% | +$9.95M |
|
Similar funds
Janus Henderson Group's Q4 2024 Portfolio in Review
As of Q4 2024, Janus Henderson Group held 2,620 positions worth $197B, up 0.7% from $195B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Janus Henderson Group's Q4 2024 filing shows 92 new, 801 increased, 713 reduced and 96 closed positions. Its largest new stake was Lam Research: 10,967,975 shares worth $792M. The largest sale was Workday, an estimated $1.22B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2024 buy was Lam Research: 10,967,975 shares worth $792M.
- Janus Henderson Group added most to Johnson & Johnson in Q4 2024, an estimated $706M increase.
- Janus Henderson Group's biggest Q4 2024 reduction was Workday, cutting an estimated $1.22B.
- Janus Henderson Group fully exited Coca-Cola Europacific Partners in Q4 2024, selling an estimated $52.4M.
- Janus Henderson Group's ten largest holdings make up 32% of its $197B portfolio in Q4 2024.
- Janus Henderson Group opened 92 new positions and closed 96 in Q4 2024.
- Janus Henderson Group's portfolio value rose 0.7% quarter-over-quarter to $197B.
Based on Janus Henderson Group's 13F filing for Q4 2024, filed 14 Feb 2025.